Group One Trading
PDSB icon

Group One Trading’s PDS Biotechnology PDSB Stock Holding History

Group One Trading’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-64,600
Closed -$65.2K – 8900
2025
Q3 		$65.2K Buy
64,600
+11,400
+21% +$13.4K ﹤0.01% 5740
2025
Q2 		$70.8K Sell
53,200
-60,800
-53% -$82.6K ﹤0.01% 5271
2025
Q1 		$136K Buy
114,000
+90,000
+375% +$128K ﹤0.01% 4355
2024
Q4 		$39.1K Sell
24,000
-196,400
-89% -$520K ﹤0.01% 5240
2024
Q3 		$842K Buy
220,400
+104,100
+90% +$347K ﹤0.01% 2446
2024
Q2 		$341K Buy
116,300
+107,100
+1,164% +$343K ﹤0.01% 2919
2024
Q1 		$36.4K Sell
9,200
-11,500
-56% -$59.2K ﹤0.01% 4969
2023
Q4 		$103K Buy
20,700
+11,700
+130% +$58.2K ﹤0.01% 4447
2023
Q3 		$45.5K Sell
9,000
-37,600
-81% -$206K ﹤0.01% 5190
2023
Q2 		$234K Buy
46,600
+40,000
+606% +$262K ﹤0.01% 3772
2023
Q1 		$40.6K Sell
6,600
-4,100
-38% -$33.5K ﹤0.01% 5004
2022
Q4 		$141K Buy
10,700
+10,400
+3,467% +$73.4K ﹤0.01% 4145
2022
Q3 		$1K Buy
+300
New +$1.27K ﹤0.01% 7361
2021
Q4 		– Sell
-300
Closed -$4K – 8695
2021
Q3 		$4K Buy
300
+100
+50% +$1.25K ﹤0.01% 7816
2021
Q2 		$3K Buy
+200
New +$1.56K ﹤0.01% 7879

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's PDSB Position: Q1 2026 in Review

Group One Trading reduced its PDS Biotechnology (PDSB) stake by 9.1% in Q1 2026, selling an estimated $267 and leaving 3,567 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #7028.

Group One Trading first reported a position in PDSB in Q1 2018 and has held it in 27 quarters since. The position peaked at $264K in Q4 2023. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Group One Trading held 3,567 shares of PDS Biotechnology worth $2.16K as of Q1 2026.
  • Group One Trading sold 355 PDS Biotechnology shares in Q1 2026, an estimated $267.
  • PDS Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7028 holding.
  • Group One Trading first reported a position in PDS Biotechnology in Q1 2018 and has held it in 27 quarters since.
  • Group One Trading's PDS Biotechnology position peaked at $264K in Q4 2023.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.